Source: Virtual Congress 2020 – Chronic lung diseases: novel methods, diagnostics and biomarkers
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
J. Huang (Dundee, United Kingdom), Y. Gao (Dundee, United Kingdom), A. Barton (Dundee, United Kingdom), H. Richardson (Dundee, United Kingdom), H. Leyah (Dundee, United Kingdom), H. Barclay (Dundee, United Kingdom), E. Kuzmanova (Dundee, United Kingdom), H. Keir (Dundee, United Kingdom), A. Dicker (Dundee, United Kingdom), J. Chalmers (Dundee, United Kingdom). Sputum proteomics identifies distinct endotypes of exacerbations in bronchiectasis. 324

Member's Comments

No comment yet.

Related content which might interest you: Sputum biomarkers in COPD exacerbations Source: Annual Congress 2011 - Monitoring exacerbations of airway diseases Year: 2011 Discriminating phenotypes of severe eosinophilic asthma using gene profiling in sputum Source: International Congress 2018 – Does asthma phenotyping improve treatment? Year: 2018 Sputum colour as a marker of acute bacterial exacerbations of COPD Source: Annual Congress 2003 - COPD - basic mechanisms and therapy of acute exacerbations Year: 2003 Sputum proteomics of CF, BE and COPD with or without NTM infections Source: Virtual Congress 2021 – Advances in diagnosis, treatment and clinical management of nontuberculous mycobacterial disease Year: 2021 Biomarkers to identify sputum eosinophilia in different adult asthma phenotypes Source: Eur Respir J 2015; 46: 688-696 Year: 2015 Overlapping biologic exacerbation clusters in asthma and chronic obstructive pulmonary disease have distinct sputum mediator and microbiome profiles Source: International Congress 2018 – Biomarkers of COPD and asthma-COPD overlap syndrome (ACOS) Year: 2018 Sputum neutrophilic markers in asthma of varying severity and COPD Source: Eur Respir J 2003; 22: Suppl. 45, 550s Year: 2003 Immunometabolic markers and the sputum microbiome in bronchiectasis Source: Virtual Congress 2021 – Bronchiectasis heterogeneity: assessing the endotypes Year: 2021 Prediction of imminent COPD exacerbations by sputum analysis Source: Eur Respir J 2003; 22: Suppl. 45, 37s Year: 2003 The biology of pulmonary exacerbations in bronchiectasis Source: Eur Respir Rev, 28 (154) 190055; 10.1183/16000617.0055-2019 Year: 2019 Eosinophils: a biological marker for bronchiectasis exacerbations? Source: International Congress 2019 – Phenotypes and endotypes of bronchiectasis Year: 2019 Changes in the induced sputum proteome during COPD exacerbations Source: Virtual Congress 2020 – Inflammatory pathways in chronic airway diseases Year: 2020 Applications of induced sputum sampling in asthma and COPD Source: School Course 2013 - Monitoring of asthma, COPD and other airway diseases Year: 2013 Endotyping of COPD, bronchiectasis and their overlap syndrome by integrated sputum proteome/microbiome Source: International Congress 2019 – Intercellular communication in tissue remodelling of chronic lung diseases Year: 2019 Sputum proteomics and airway cell transcripts of current and ex-smokers with severe asthma in U-BIOPRED: an exploratory analysis Source: Eur Respir J, 51 (5) 1702173; 10.1183/13993003.02173-2017 Year: 2018 Inflammatory markers in sputum of patients with cough variant asthma Source: Eur Respir J 2002; 20: Suppl. 38, 584s Year: 2002 Neutrophil elastase levels in sputum of patients with different airway diseases: COPD, bronchiectasis and asthma Source: Eur Respir J 2002; 20: Suppl. 38, 95s Year: 2002 Cytokine profile in sputum from non-infective exacerbation of COPD and non-atopic asthma Source: Eur Respir J 2002; 20: Suppl. 38, 252s Year: 2002 The BAL in the bacteriologic etiology in the COPD exacerbations Source: Eur Respir J 2005; 26: Suppl. 49, 299s Year: 2005 Sputum galactomannan in COPD patients with and without bronchiectasis Source: International Congress 2017 – Bronchial asthma management Year: 2017